SCHD ETF ($32.89) Yields 3.06% Against a 4.628% Ten-Year and Still Beat the S&P 500 by 6 Points — 26.51% 12-Month Total Return

The Schwab U.S. Dividend Equity ETF changed hands at $32.89 on Tuesday, with a pre-market print of $33.17 and an after-hours reference at $33.09. The 52-week range runs from $26.16 to $32.91 — meaning the fund is effectively sitting on its high, having climbed 25.7% off the low.

That is an unusual place for a dividend fund to be in a year when the 10-year Treasury yields 4.628%.

Assets under management have reached approximately $101.11 billion, crossing the $100 billion threshold earlier this year and joining a very short list of funds at that scale. Net flows over the trailing twelve months total roughly $15.35 billion. The expense ratio is 0.06%.

The performance is the part that should reframe how income investors think about this fund. SCHD has delivered a total return of 26.51% over the past twelve months and 23.36% year-to-date through July 24, with dividends reinvested — and it currently sits at its all-time total-return high. Over the same trailing year, the S&P 500 returned roughly 20.6%.

A dividend fund yielding 3% has beaten the index by nearly six percentage points during a period dominated by artificial intelligence capital expenditure. That is not what dividend funds are supposed to do, and understanding why it happened is the entire analysis.

The distribution is $0.257 quarterly, roughly $1.05 over the trailing twelve months, producing a yield between 3.06% and 3.3% depending on the reference price used. The last ex-dividend date was June 24. The fund is on pace to complete its fifteenth consecutive year of payout increases in 2026.

Since inception on October 20, 2011, SCHD has produced a nominal total return of 537.62%, compounding at 13.37% annually.

The tape today is exactly the environment this fund was built for. Dow futures are up 0.51% while Nasdaq futures fall 1.04% on a semiconductor rout that took South Korea's benchmark down 10.84%. Coca-Cola beat and raised guidance this morning on 5% volume growth. UPS beat and raised. Money is rotating out of the AI complex and into cash-generating businesses.

The Federal Reserve announces Wednesday at 2 p.m. Eastern with the target range at 3.50% to 3.75% and implied hike odds near 36%. For a bond-proxy asset sitting at a 52-week high, that decision matters more than any holding in the portfolio.

A 3.06% Yield Against a 4.628% Ten-Year Should Not Work

The bond-proxy comparison is where most dividend-fund analysis begins and ends, and on the surface SCHD loses it badly.

The 10-year Treasury yields 4.628%. The 2-year yields 4.306%. The 30-year sits at 5.121%. SCHD yields between 3.06% and 3.3%. An investor choosing between the two is being asked to accept roughly 130 to 160 basis points less current income in exchange for equity risk.

On a pure income basis that is a poor trade, and it explains why dividend funds broadly underperformed through the 2023 to 2025 rate cycle. When cash paid 5%, the case for owning equities to generate 3% collapsed.

Two things changed that calculus in 2026.

The first is growth. A Treasury coupon is fixed for the life of the bond. SCHD's distribution has risen in each of the past fourteen years and is on pace for a fifteenth. An investor buying at $32.89 today receives roughly $1.05 annually. If the payout compounds at even 6% — well below the fund's historical rate — that same position yields 4.1% on original cost within five years and 5.5% within ten. The Treasury still pays 4.628% in year ten and returns par.

The second is that the price appreciated. A 3.06% yield on a fund that gained 23.36% year-to-date produced a total return of 26.51% over twelve months. The bond produced its coupon and a capital loss as yields rose.

That distinction — yield versus total return — is the one most income analysis gets wrong. SCHD is not a fixed-income substitute. It is an equity fund whose selection screens happen to produce an above-market payout, and the payout is a byproduct of the strategy rather than its objective.

The vulnerability in that framing is real and worth stating. If rates rise further from here — and roughly 80% odds of a September Fed hike are currently priced — the discount rate applied to every future dividend rises with them. Bond-proxy equities carry duration whether or not anyone labels it as such, and SCHD sitting at a 52-week high with a 3% yield has less cushion than it did at $26.16.

That is the risk Wednesday afternoon tests directly.

The Payout Has Risen Fourteen Consecutive Years

The dividend growth record is the fund's central asset and the reason its yield understates its income proposition.

SCHD has increased its distribution every year since inception and is on pace to complete a fifteenth consecutive year of increases in 2026. Trailing twelve-month payments total roughly $1.05 per share, delivered in quarterly instalments most recently at $0.257.

The mechanism behind that consistency is the index construction rather than any manager decision. The underlying methodology requires companies to have a ten-year history of paying dividends before they even enter the selection universe. Within that universe, the screens weight dividend growth rate alongside yield, which systematically favours companies that raise rather than merely maintain.

That construction produces a specific and valuable exclusion: the fund will not hold small, speculative firms offering attractive distribution yields because their share prices have collapsed. High yield alone does not qualify a company for inclusion, which is why SCHD avoids the yield traps that have damaged simpler high-dividend strategies.

The practical consequence for an income investor is compounding. Reinvested distributions purchase additional shares, which generate additional distributions, which purchase more shares — while the per-share payout itself rises. Over the fund's fourteen-year history that combination produced a 537.62% nominal total return against a price appreciation figure substantially lower.

The distinction between price return and total return is where dividend funds earn their keep and where headline charts mislead. SCHD's price has risen 25.01% over the past year. Its total return with dividends reinvested is 26.85% on a net asset value basis. That 184-basis-point gap is one year of income; over a decade the gap becomes the majority of the return.

The forward risk to this record is earnings growth. Analysis of the current portfolio has flagged that earnings growth remains a relative challenge compared with pure growth funds, and payout increases cannot outrun earnings indefinitely. Payout ratios and sustainability metrics showed slight fundamental improvement after this year's reconstitution — marginally better three-year EPS compound growth and a lower trailing price-to-earnings ratio — but the underlying constraint has not changed.

Fourteen years of increases is a record. It is not a guarantee, and the fifteenth requires the portfolio's earnings to cooperate.

The March Reconstitution Cut Energy by Eight Percentage Points

The annual rebuild is not an administrative event. It is a deliberate capital reallocation, and this year's was among the most consequential in the fund's history.

The 2026 reconstitution took effect on March 23, implemented after the close on March 20. It added 25 new companies and removed 22 existing holdings — roughly a quarter of the portfolio turned over in a single session.

The headline shift was energy. Sector exposure was cut by approximately eight percentage points from a weighting that had ballooned to roughly 20% to 21% in the prior portfolio. That trimming moved capital from cyclical volatility toward more stable, quality-driven cash flows.

The additions tell the strategic story. UnitedHealth entered at the 4% cap, immediately becoming one of the largest holdings. Abbott Laboratories arrived with meaningful weight. Procter & Gamble, Qualcomm, Accenture, Comcast, and Automatic Data Processing all landed just outside the top ten. Three new names entered the top ten outright.

The removals were equally notable. AbbVie and Cisco — two of the fund's largest prior positions — were dropped, alongside Halliburton, Valero Energy, and Packaging Corporation.

Removal does not signal deterioration. The index recalibrates annually based on relative ranking across all eligible candidates on free cash flow to total debt, return on equity, dividend yield, and five-year dividend growth rate. Stocks exit when other candidates score more favourably on the composite, not because the business broke.

The comparison to the prior year explains why this matters so much. In 2025, the reconstitution moved financials from roughly 17% of the portfolio to about 8.5% while lifting energy from 12% to 21%. That single reallocation preceded a substantial energy rally and was a major reason the fund became an elite performer in 2026.

The mechanical nature of the process produces an uncomfortable characterisation: this year's rebalance was essentially a buy-low, sell-high transaction that locked in energy gains and rotated into value plays that had finally met the entry criteria. That is disciplined. It also means the fund systematically sells what has worked and buys what has not, which sacrifices momentum.

Through March, SCHD was up nearly 13% year-to-date while the broader index struggled.

UnitedHealth Is Now the Largest Holding and Healthcare Owns the Top Four

The quarterly rebalance completed in June, with holdings data updated July 8, pushed the portfolio into an even more defensive configuration.

UnitedHealth has taken the number one position at 4.49% of assets, overtaking Home Depot. Healthcare names now occupy all four of the largest positions: UnitedHealth, Merck, Abbott, and Amgen.

Verizon slipped out of the top ten entirely and Chevron moved in — a rotation that reads as the fund reducing telecom exposure and retaining a single large energy position after March's sector cut. Technology exposure continues to shrink, with Texas Instruments and Qualcomm sliding to a combined 6.85%.

The quarterly rebalance is a different exercise from the annual reconstitution. It does not add or remove holdings; it redistributes weight across existing positions to enforce concentration limits, occurring on the third Friday of March, June, September, and December.

The current portfolio holds 103 positions. The top ten account for approximately 41.19% of total assets — a concentration figure that deserves attention. Nearly half the fund sits in ten companies, which is substantially more concentrated than a broad market index and is a direct consequence of the 4% individual security cap combined with market-cap weighting.

That concentration is the fund's principal single-name risk. UnitedHealth at 4.49% means one company's regulatory or operational stumble moves the fund by roughly 4.5 basis points for every percentage point it declines.

The defensive tilt has strengthened materially through 2026, and today's tape validates it. A semiconductor rout that dropped South Korea's benchmark 10.84% and Nasdaq futures 1.04% touches almost nothing in this portfolio. Healthcare, consumer staples, and industrials do not carry memory-chip exposure or AI capital expenditure risk.

The corresponding cost is participation. Nasdaq-100 futures at 27,897 reflect an index that has compounded on exactly the exposure SCHD systematically excludes. A fund holding UnitedHealth, Merck, Abbott, and Amgen at the top does not capture an AI infrastructure rally.

That trade-off has been unprofitable for three years and profitable for the past twelve months, which is the entire case for owning both.

The Four Screens That Define What SCHD Will Not Own

The methodology is worth understanding in detail because it explains both the fund's resilience and its structural blind spots.

The selection universe requires a ten-year history of paying dividends. That single filter eliminates every company that has cut, suspended, or initiated a dividend within the past decade — which removes most of the technology sector's newer payers and all of the speculative high-yield names that populate simpler screens.

Within that universe, four fundamental metrics determine ranking: free cash flow to total debt, return on equity, dividend yield, and five-year dividend growth rate. The first two are balance-sheet quality measures. The second two are income measures. A company must score well on the composite, not on any single factor.

Weighting follows a modified market-capitalisation approach with hard caps. No individual security exceeds 4% of the index. No sector exceeds 25%. Those constraints prevent the concentration that pure market-cap weighting would produce and are the reason a $101 billion fund holding 103 names does not simply become a mirror of the largest dividend payers.

Real estate investment trusts are excluded entirely. That is a significant and deliberate omission — REITs are the highest-yielding equity sector and the most rate-sensitive. Excluding them removes both the yield they would add and the duration risk they carry. In a year where the 10-year has run at 4.628%, that exclusion has been worth real performance.

The result is a modest large-cap tilt and a portfolio classified as large value.

The acknowledged flaw is that the mechanical rules prioritise backward-looking metrics. A ten-year dividend history and a five-year growth rate describe what a company did, not what it will do. That is why the fund captures established cash generators well and misses inflection points entirely — it cannot own a business until that business has already proven itself for a decade.

For an income investor, backward-looking is a feature. Dividends are paid from realised cash flow, not projected cash flow, and a screen that demands a decade of evidence is precisely the screen that avoids cuts.

For a total-return investor, it is a constraint that caps upside in exchange for reducing the probability of permanent capital loss.

Dividend Funds Are Drawing Capital and SCHD Is Taking the Largest Share

The flow picture in 2026 has been the strongest for income strategies in years, and it explains the $100 billion milestone.

US dividend income funds have attracted strong flows through the year as investors seek safety, and the breadth of the move is notable — nearly 90 of more than 120 US dividend equity ETFs have posted positive year-to-date returns.

SCHD has taken a disproportionate share. Net flows over the trailing twelve months total roughly $15.35 billion. Assets have climbed from approximately $92.77 billion earlier in the year to $96.05 billion in early June to $101.11 billion now.

The fund crossed $100 billion in assets this year, joining a category of mega-funds that until recently was populated almost entirely by broad-market index products. For context on how rare that threshold is, the first ETF to reach it was the original S&P 500 tracker.

The competitive comparison sharpens the picture. Following the market disruption of April 2025, SCHD drew $1.19 billion in net inflows — nearly double what the largest dividend-growth competitor attracted over the same window. When income investors rotate, they rotate here first.

The 0.06% expense ratio is a substantial part of that. On $101 billion of assets, that fee generates roughly $61 million annually — a fraction of what competing active income strategies charge, and a permanent structural advantage that compounds into relative performance every year.

The flow persistence matters more than any single month's total. A fund adding $15 billion over twelve months while gaining 26.51% in total return is experiencing both price appreciation and genuine new allocation, which is a different and healthier configuration than asset growth driven purely by market movement.

The forward risk is that the same flows reverse if rates rise sharply. Income allocators who rotated into dividend equities because Treasury yields looked unattractive at 4% may rotate back if the 10-year approaches 5%, and $101 billion of assets creates redemption pressure that a smaller fund would not face.

That is the specific mechanism by which a hawkish Fed damages this fund beyond the discount-rate effect.

What Today's Tape Says About Whether the Rotation Is Real

Tuesday's session is a live demonstration of the environment SCHD is constructed for.

Dow futures are up 0.51% at 52,648 while Nasdaq-100 futures fall 1.04% to 27,897. The divergence stems from a semiconductor collapse that took South Korea's benchmark down 10.84%, tripped a circuit breaker, and dropped Samsung 14.4% and SK Hynix 14.7%. Japan's Nikkei fell 3.95%.

None of that touches this portfolio.

What does touch it is the earnings flow. Coca-Cola reported adjusted earnings of $0.97 against $0.93 expected on revenue of $13.38 billion, up 7%, with unit case volume growing 5% across every reporting segment, and raised full-year guidance. UPS beat by ten cents and raised full-year revenue to approximately $91.2 billion. Boeing generated $631 million in free cash flow against an expected burn.

Those are the businesses SCHD's screens are designed to identify: established cash generators whose earnings are disconnected from AI infrastructure spending.

Monday's Dow leadership told the same story, with Salesforce up 5.39%, 3M up 3.17%, and Sherwin-Williams up 3.05% while Nvidia fell 4.97%.

The energy position is the swing factor within the portfolio. Chevron moved into the top ten during the June rebalance, and Brent crude has collapsed roughly 10% across three sessions to $87.05 as the US-Iran pause held. That is a headwind to the fund's remaining energy weight and a reminder of why March's eight-point reduction was well-timed.

The offsetting effect is broader. Cheaper energy lowers input costs for every industrial and consumer staples holding in the portfolio, which supports margins across a far larger share of assets than the energy weight represents. A fund that cut energy exposure and holds Coca-Cola, Procter & Gamble, and Home Depot benefits from falling crude on net.

Consumer confidence printed Tuesday against a June reading of 91.2 with the expectations index at 74.4 — below the recession threshold since February 2025. That weakness is the argument for owning defensive cash flows rather than against it.

The rotation is real. Whether it survives Wednesday afternoon is a rates question, not an earnings question.